SK282476B6 - Derivát benzylpiperidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje - Google Patents

Derivát benzylpiperidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje Download PDF

Info

Publication number
SK282476B6
SK282476B6 SK1355-95A SK135595A SK282476B6 SK 282476 B6 SK282476 B6 SK 282476B6 SK 135595 A SK135595 A SK 135595A SK 282476 B6 SK282476 B6 SK 282476B6
Authority
SK
Slovakia
Prior art keywords
formula
benzyl
piperidyl
derivative according
oxopropyl
Prior art date
Application number
SK1355-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK135595A3 (en
Inventor
Helmut Pr�cher
Rudolf Gottschlich
Joachim Leibrock
Harry Schwartz
Original Assignee
Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4438810A external-priority patent/DE4438810A1/de
Priority claimed from DE1995126269 external-priority patent/DE19526269A1/de
Application filed by Merck Patent Gesellschaft Mit Beschr�Nkter Haftung filed Critical Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Publication of SK135595A3 publication Critical patent/SK135595A3/sk
Publication of SK282476B6 publication Critical patent/SK282476B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1355-95A 1994-10-31 1995-10-30 Derivát benzylpiperidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje SK282476B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4438810A DE4438810A1 (de) 1994-10-31 1994-10-31 Benzylpiperidinderivate
DE1995126269 DE19526269A1 (de) 1995-07-19 1995-07-19 Benzylpiperidinderivate

Publications (2)

Publication Number Publication Date
SK135595A3 SK135595A3 (en) 1996-06-05
SK282476B6 true SK282476B6 (sk) 2002-02-05

Family

ID=25941544

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1355-95A SK282476B6 (sk) 1994-10-31 1995-10-30 Derivát benzylpiperidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje

Country Status (23)

Country Link
US (1) US5698553A (zh)
EP (1) EP0709384B1 (zh)
JP (1) JPH08225569A (zh)
KR (1) KR100388593B1 (zh)
CN (1) CN1064358C (zh)
AT (1) ATE174915T1 (zh)
AU (1) AU703487B2 (zh)
BR (1) BR9505008A (zh)
CA (1) CA2161618A1 (zh)
CZ (1) CZ288039B6 (zh)
DE (1) DE59504622D1 (zh)
DK (1) DK0709384T3 (zh)
ES (1) ES2128629T3 (zh)
FI (1) FI955184A (zh)
GR (1) GR3029771T3 (zh)
HU (1) HUT76068A (zh)
NO (1) NO310023B1 (zh)
PL (1) PL182210B1 (zh)
RU (1) RU2160259C2 (zh)
SK (1) SK282476B6 (zh)
TR (1) TR199501331A2 (zh)
TW (1) TW394770B (zh)
UA (1) UA41927C2 (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2128629T3 (es) * 1994-10-31 1999-05-16 Merck Patent Gmbh Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos.
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
DE19643790A1 (de) * 1996-10-30 1998-05-07 Merck Patent Gmbh Benzoxazol-Derivat
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses
AU6852898A (en) * 1997-04-17 1998-11-11 Takeda Chemical Industries Ltd. Thermogenic composition and benzazepine thermogenics
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
DE19812331A1 (de) 1998-03-20 1999-09-23 Merck Patent Gmbh Piperidinderivate
US6867209B1 (en) 1998-05-22 2005-03-15 Scios, Inc. Indole-type derivatives as inhibitors of p38 kinase
NZ508790A (en) * 1998-05-22 2003-10-31 Scios Inc Heterocyclic compounds and methods to treat cardiac failure and other disorders
US6589954B1 (en) 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6340685B1 (en) 1998-05-22 2002-01-22 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6130235A (en) * 1998-05-22 2000-10-10 Scios Inc. Compounds and methods to treat cardiac failure and other disorders
US6448257B1 (en) 1998-05-22 2002-09-10 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
PE20000728A1 (es) 1998-06-26 2000-08-21 Cocensys Inc Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
IL146309A (en) 1999-05-21 2008-03-20 Scios Inc Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
DE10120159A1 (de) * 2001-04-25 2002-10-31 Merck Patent Gmbh NMDA-Antagonisten und NMDA-Agonisten zur Behandlung von Suchterkrankungen
WO2003035641A1 (fr) * 2001-10-22 2003-05-01 Shionogi & Co., Ltd. Nouveau derive carbamoyl-pyrrolidone
DE10210779A1 (de) 2002-03-12 2003-10-09 Merck Patent Gmbh Cyclische Amide
DE10217006A1 (de) 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
BR0311871A (pt) * 2002-06-11 2005-03-15 Univ California Método e sistema para pesquisa geológica do solo oceânico usando a medida do campo elétrico vertical
JPWO2005097782A1 (ja) * 2004-04-07 2007-08-16 協和醗酵工業株式会社 ピペリジン誘導体
AU2007342365B2 (en) * 2007-01-03 2012-11-15 Les Laboratoires Servier 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
DE102007047737A1 (de) 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidin- und Piperazinderivate
TWI410420B (zh) * 2008-02-05 2013-10-01 Dainippon Sumitomo Pharma Co 苄基哌啶化合物
KR20120051716A (ko) 2009-08-04 2012-05-22 다이닛본 스미토모 세이야꾸 가부시끼가이샤 벤질피페리딘 화합물
DE102009049211A1 (de) 2009-10-13 2011-04-28 Merck Patent Gmbh Sulfoxide
US20130270486A1 (en) * 2010-12-21 2013-10-17 Sumitomo Chemical Company, Limited Polymer compound and light-emitting device using same
US9837612B2 (en) * 2010-12-21 2017-12-05 Sumitomo Chemical Company, Limted Polymer compound and light-emitting device using same
KR102277538B1 (ko) * 2015-06-08 2021-07-14 주식회사 대웅제약 신규한 헤테로 고리 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물
AR110963A1 (es) * 2017-02-07 2019-05-22 Dae Woong Pharma Compuestos heterocíclicos, su método de preparación y composición farmacéutica que los comprende

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
JPS57142972A (en) * 1981-02-27 1982-09-03 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
JPH0753913B2 (ja) * 1990-11-14 1995-06-07 新日本製鐵株式会社 有機複合めっき鋼板の製造方法
US5338361A (en) * 1991-11-04 1994-08-16 Measurex Corporation Multiple coat measurement and control apparatus and method
FR2688504B1 (fr) * 1992-03-13 1995-05-05 Synthelabo Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
ES2128629T3 (es) * 1994-10-31 1999-05-16 Merck Patent Gmbh Derivados de bencilpiperidina con afinidad elevada a puntos de enlace de receptores de aminoacidos.

Also Published As

Publication number Publication date
FI955184A (fi) 1996-05-01
TW394770B (en) 2000-06-21
SK135595A3 (en) 1996-06-05
EP0709384A1 (de) 1996-05-01
KR100388593B1 (ko) 2003-09-19
ES2128629T3 (es) 1999-05-16
KR960014119A (ko) 1996-05-22
HU9503101D0 (en) 1995-12-28
JPH08225569A (ja) 1996-09-03
US5698553A (en) 1997-12-16
EP0709384B1 (de) 1998-12-23
AU703487B2 (en) 1999-03-25
AU3443595A (en) 1996-05-09
TR199501331A2 (tr) 1996-06-21
CA2161618A1 (en) 1996-05-01
CZ288039B6 (cs) 2001-04-11
NO310023B1 (no) 2001-05-07
CN1128762A (zh) 1996-08-14
UA41927C2 (uk) 2001-10-15
CZ281695A3 (en) 1996-05-15
PL311185A1 (en) 1996-05-13
CN1064358C (zh) 2001-04-11
BR9505008A (pt) 1997-10-14
FI955184A0 (fi) 1995-10-30
GR3029771T3 (en) 1999-06-30
NO954349L (no) 1996-05-02
PL182210B1 (pl) 2001-11-30
DE59504622D1 (de) 1999-02-04
RU2160259C2 (ru) 2000-12-10
HUT76068A (en) 1997-06-30
DK0709384T3 (da) 1999-08-23
ATE174915T1 (de) 1999-01-15
NO954349D0 (no) 1995-10-30

Similar Documents

Publication Publication Date Title
SK282476B6 (sk) Derivát benzylpiperidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
CA1337817C (en) Heterocyclic spiro compounds and methods for preparing the same
US4748182A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
HU214578B (hu) Eljárás aril-acetamidok, valamint hatóanyagként ezen vegyületeket tartalmazó gyógyászati készítmények előállítására
WO1997047601A1 (fr) Composes heterocycliques fusionnes et leurs utilisations medicinales
JPH02500910A (ja) ベンゾ〔５，６〕シクロヘプタピリジン類、組成物および使用法
CS201040B2 (en) Method of producing etherified hydroxy-benzo-diheterocyclic compounds
CZ18593A3 (en) Benzimidazolyl derivatives, medicaments in which said compounds are comprised, and process for producing thereof
EP0433149B1 (fr) Antagonistes de la sérotonine, leur préparation et les médicaments les contenant
JPH0717633B2 (ja) ヘテロアリールピペラジン抗精神病薬
SK50895A3 (en) 3-indolylpiperidine derivative, method of its preparation, its use for preparation of pharmaceutical composition and pharmaceutical composition containing them
SK13692000A3 (sk) Derivát 1-(3-heteroarylpropyl- alebo -prop-2-enyl)-4-benzylpiperidínu ako antagonistu nmda receptora, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
SK26995A3 (en) Single acetamides for suppressing of diseases method of their production and their using for production of medicines pharmaceutical agents on their base and method of their production
SK141998A3 (en) Piperidines and pyrrolidines
CA2076146A1 (en) Piperidine derivatives
US5194440A (en) Substituted cyclic sulphamide derivatives
NO309038B1 (no) Fenylindolforbindelser
SK99298A3 (en) 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system
US5344927A (en) Tetrahydrobenzimidazole derivatives and pharmaceutical compositions containing same
SK106196A3 (en) Piperidinyl methyloxazolidinone derivative, preparation method thereof and pharmaceutical composition containing its
US4789676A (en) Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives, usefull as anxiolytic agents
US5077295A (en) Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides
IE64209B1 (en) New indole derivatives process for preparing them and pharmaceutical compositions containing them
JP2003081978A (ja) スピロ環式化合物およびその医薬用途
EP0553130A1 (en) PYRROLIDINE DIONE DERIVATIVES.